Beyond the Hype: What GLP-1s Mean for Policy and Employers episode artwork

EPISODE · Sep 23, 2025 · 41 MIN

Beyond the Hype: What GLP-1s Mean for Policy and Employers

from Pop Health Podcast · host Meg and Melissa

GLP-1 medications like Ozempic and Wegovy have quickly moved from niche treatments to the center of high-stakes conversations across payers about cost, access, and coverage. In this episode, Coral Partner Alison Falb talks with Laura Rudder Huff, Vice President at Gallagher Research & Insights, about how the rise of GLP-1s is shaping employer benefit strategies, equity considerations, and policy debates.  

Episode metadata supplied by the publisher feed · Published Sep 23, 2025

Embed this episode

Ready to play

Beyond the Hype: What GLP-1s Mean for Policy and Employers

0:00 41:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Pop Health Podcast?

This episode is 41 minutes long.

When was this Pop Health Podcast episode published?

This episode was published on September 23, 2025.

Can I download this Pop Health Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!